No difference in mortality in moderate-severe ARDS patients treated with neuromuscular blockade vs usual care. https://t.co/DyLdhDt7XR
Les résultats de l'étude ROSE sur l'intérêt des curares dans le SDRA modéré/sévère ont été publiés dans le @NEJM lors de l' #ats2019 https://t.co/57BbFjclx1 Un éditorial associé est également disponible: https://t.co/kiporPhv3j Une analyse approfondie
RT @ventilacionmeca: Se acabó la infusión continua de relajantes musculares empleados de forma sistemática en SDRA. https://t.co/p3dtkQiG2V
RT @NEJM: Original Article: Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome (ROSE) https://t.co/lcLOUi9RXe #ATS2019…
RT @SheelaPaiCole: PETAL in NEJM. NMB in ARDS #nohelp @SOCCA_CritCare #anesthesia @vmoitra @MdVeena @tbenjaco @mike_wall61 @Greg…
RT @NEJM: Original Article: Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome (ROSE) https://t.co/lcLOUi9RXe #ATS2019…
RT @NEJM: Original Article: Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome (ROSE) https://t.co/lcLOUi9RXe #ATS2019…
RT @NEJM: Original Article: Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome (ROSE) https://t.co/lcLOUi9RXe #ATS2019…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @NEJM: Original Article: Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome (ROSE) https://t.co/lcLOUi9RXe #ATS2019…
RT @JBLascarrou: Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome | NEJM https://t.co/7LaTusuqsL
RT @NEJM: Original Article: Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome (ROSE) https://t.co/lcLOUi9RXe #ATS2019…
RT @NEJM: Original Article: Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome (ROSE) https://t.co/lcLOUi9RXe #ATS2019…
Original Article: Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome (ROSE) https://t.co/lcLOUi9RXe #ATS2019 Editorial: Early Paralytic Agents for ARDS? Yes, No, and Sometimes https://t.co/EffcYcPUyb #ATS2019 https://t.co/JsagqI72bh
RT @ccpractitioner: @bryanboling here's a great example of the power of Twitter-published today. No difference between those paralysed and…
RT @ventilacionmeca: Se acabó la infusión continua de relajantes musculares empleados de forma sistemática en SDRA. https://t.co/p3dtkQiG2V
RT @matthewjrowland: Time to rethink NMB in ARDS? (via @CritCareReviews) https://t.co/EGnPwUewbw Need to properly digest this. Effects of…
@bryanboling here's a great example of the power of Twitter-published today. No difference between those paralysed and those not.... https://t.co/Nas0DAJVOC
ROSE Trial https://t.co/AbHc8muEhz A decade after ACURASYS, ROSE compares NMB + deep sedation vs lighter sedation only in ARDS, reports no difference in mortality, hospital/ ICU use, PROMS. Interesting secondary CVS and activity outcomes. https://t.co/SD6j
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @ventilacionmeca: Se acabó la infusión continua de relajantes musculares empleados de forma sistemática en SDRA. https://t.co/p3dtkQiG2V
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @ventilacionmeca: Se acabó la infusión continua de relajantes musculares empleados de forma sistemática en SDRA. https://t.co/p3dtkQiG2V
RT @SheelaPaiCole: PETAL in NEJM. NMB in ARDS #nohelp @SOCCA_CritCare #anesthesia @vmoitra @MdVeena @tbenjaco @mike_wall61 @Greg…
RT @ventilacionmeca: Se acabó la infusión continua de relajantes musculares empleados de forma sistemática en SDRA. https://t.co/p3dtkQiG2V
Great demonstration of why high quality clinical research in the ICU can be so expensive and time consuming.
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @emeddoc: Very interesting results from the #PETALnetwork #ROSE trial - maybe early NMB use in moderate-severe ARDS has no benefit after…
No difference in mortality in NMB vs normal sedation stratagies in Ards. Bit of a suprise https://t.co/5ywWEQTMX9
RT @emeddoc: Very interesting results from the #PETALnetwork #ROSE trial - maybe early NMB use in moderate-severe ARDS has no benefit after…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @SheelaPaiCole: PETAL in NEJM. NMB in ARDS #nohelp @SOCCA_CritCare #anesthesia @vmoitra @MdVeena @tbenjaco @mike_wall61 @Greg…
RT @intensivecare_c: ROSE trialが発表になりました! 中等症~重症ARDS(PEEP≧8でP/F比<150)には早期に筋弛緩をした方が良いのか?を検証したRCT 筋弛緩群(cisatracurium)とコントロール群で死亡率に有意差なし、という…
RT @SheelaPaiCole: PETAL in NEJM. NMB in ARDS #nohelp @SOCCA_CritCare #anesthesia @vmoitra @MdVeena @tbenjaco @mike_wall61 @Greg…
RT @DocMusician: Bloqueo neuromuscular en SIRA, que dijo mi mamá que siempre no :( https://t.co/RhbamyQlXr
RT @mgdrake: Huge congrats to my colleague @bronchoscope for his tireless commitment to his patients and to this study. Could not have bee…
Another thing to cross off the list of things I think I know... https://t.co/mkYhiBTYD5 .. but maybe a good example of why older evidence has to continually be re evaluated as other care practices change over time
https://t.co/yR5ns2Ztfc Relajantes en SDRA? Parece que no siempre
RT @semicyuc: The benefits of early continuous neuromuscular blockade in patients with acute respiratory distress syndrome (ARDS) who are r…
RT @msiuba: I’m not sure anything is surprising about #ROSE results. https://t.co/BTwWwAroT4 That said, how will this affect your practice…
RT @YaseenarabiYa: PETAL trial: Continuous cisatracurium infusion vs usual care with lighter sedation levels, 1006 patients with moderate-t…
Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome #LessIsMore #ICU https://t.co/iodEFGjQVQ
RT @ventilacionmeca: Se acabó la infusión continua de relajantes musculares empleados de forma sistemática en SDRA. https://t.co/p3dtkQiG2V
PETAL in NEJM. NMB in ARDS #nohelp @SOCCA_CritCare #anesthesia @vmoitra @MdVeena @tbenjaco @mike_wall61 @Greg_Blair_MD @smccartney31 @mswami001 https://t.co/Sz1iCwrWlt
Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome | NEJM https://t.co/s3vPUHCYzz
RT @VirtueOfNothing: So that’s 1/3 evidence based interventions for ARDS out the window? 🤔 Early Neuromuscular Blockade in the Acute Respir…
RT @EuroELSO: Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome | NEJM https://t.co/IkCKI13ZLZ This trial revisited r…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @DocMusician: Bloqueo neuromuscular en SIRA, que dijo mi mamá que siempre no :( https://t.co/RhbamyQlXr
Interesting...
Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome, high PEEP might be enough https://t.co/QVjbsU480g
I’m not sure anything is surprising about #ROSE results. https://t.co/BTwWwAroT4 That said, how will this affect your practice? (See next tweet)
RT @semicyuc: The benefits of early continuous neuromuscular blockade in patients with acute respiratory distress syndrome (ARDS) who are r…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @gsmartinmd: The #PETALnetwork #ROSEtrial does not support use of paralytics in moderate-severe #ARDS patients, with no outcome benefit…
RT @YaseenarabiYa: PETAL trial: Continuous cisatracurium infusion vs usual care with lighter sedation levels, 1006 patients with moderate-t…
RT @ventilacionmeca: Se acabó la infusión continua de relajantes musculares empleados de forma sistemática en SDRA. https://t.co/p3dtkQiG2V
RT @DDKrutsinger: The ROSE trial conducted by the PETAL network required 268 investigators, coordinators, & staff to enroll 1006 patients.…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @DrSamuelBrown: Yup. Turns out control groups probably do matter and relentlessly deep sedation isn't good for you. Glad to be freed of…
RT @ventilacionmeca: Se acabó la infusión continua de relajantes musculares empleados de forma sistemática en SDRA. https://t.co/p3dtkQiG2V
RT @ventilacionmeca: Se acabó la infusión continua de relajantes musculares empleados de forma sistemática en SDRA. https://t.co/p3dtkQiG2V
RT @YaseenarabiYa: PETAL trial: Continuous cisatracurium infusion vs usual care with lighter sedation levels, 1006 patients with moderate-t…
RT @YaseenarabiYa: PETAL trial: Continuous cisatracurium infusion vs usual care with lighter sedation levels, 1006 patients with moderate-t…
RT @dr_supradip: #ROSE vs #ACURASYS. Beneficial effect of light sedation over deep sedation and overall impact of fluid restriction negated…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
Hold off the paralysis in ARDS Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome | NEJM https://t.co/DKgAxuQX76
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @ogi_gajic: Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome | NEJM https://t.co/dNA9zfLC2F
RT @a3cordier: Interesting results. A few recent trails suggest we might not know what we thought we knew... even about things we were pre…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @KlgiaRespCrit: This is the end 🎶The bloking end... the end🎶 #PETALnetwork https://t.co/ubiPhiQoPa
RT @ventilacionmeca: Se acabó la infusión continua de relajantes musculares empleados de forma sistemática en SDRA. https://t.co/p3dtkQiG2V
RT @ventilacionmeca: Resultados del bloqueo neuromuscular en SDRA. Todos los tratamientos deben ser personalizados https://t.co/apG9Uln0KR
RT @ventilacionmeca: Se acabó la infusión continua de relajantes musculares empleados de forma sistemática en SDRA. https://t.co/p3dtkQiG2V
RT @ventilacionmeca: Resultados del bloqueo neuromuscular en SDRA. Todos los tratamientos deben ser personalizados https://t.co/apG9Uln0KR
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @ventilacionmeca: Se acabó la infusión continua de relajantes musculares empleados de forma sistemática en SDRA. https://t.co/p3dtkQiG2V
Interesting results. A few recent trails suggest we might not know what we thought we knew... even about things we were pretty sure off 😳 #evidencebasedmedicine
RT @YaseenarabiYa: PETAL trial: Continuous cisatracurium infusion vs usual care with lighter sedation levels, 1006 patients with moderate-t…
RT @YaseenarabiYa: PETAL trial: Continuous cisatracurium infusion vs usual care with lighter sedation levels, 1006 patients with moderate-t…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
another #icu #ards treatment challenged #ats19 Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome | @NEJM https://t.co/5PBpLNbUXS
RT @gsmartinmd: The #PETALnetwork #ROSEtrial does not support use of paralytics in moderate-severe #ARDS patients, with no outcome benefit…
RT @YaseenarabiYa: PETAL trial: Continuous cisatracurium infusion vs usual care with lighter sedation levels, 1006 patients with moderate-t…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
Wholeheartedly agree. I have fond memories of @bronchoscope stalking p:f ratios in the chart night and day.
RT @semicyuc: The benefits of early continuous neuromuscular blockade in patients with acute respiratory distress syndrome (ARDS) who are r…
RT @lyvonnetume: Are we using too much NMB in PICUs? @CHCR_UWE @BristolPICRese1 @adrianhumphry @PICSociety @PICSNurses @davidgrantsim @Alvi…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
Are we using too much NMB in PICUs? @CHCR_UWE @BristolPICRese1 @adrianhumphry @PICSociety @PICSNurses @davidgrantsim @AlvinSchadenbe1 @mattdc78
RT @ventilacionmeca: Se acabó la infusión continua de relajantes musculares empleados de forma sistemática en SDRA. https://t.co/p3dtkQiG2V
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @YaseenarabiYa: PETAL trial: Continuous cisatracurium infusion vs usual care with lighter sedation levels, 1006 patients with moderate-t…
RT @NEJM: This trial revisited research conducted about a decade ago that showed a survival benefit with early neuromuscular blockade in pa…
RT @intensivecare_c: ROSE trialが発表になりました! 中等症~重症ARDS(PEEP≧8でP/F比<150)には早期に筋弛緩をした方が良いのか?を検証したRCT 筋弛緩群(cisatracurium)とコントロール群で死亡率に有意差なし、という…
RT @DocMusician: Bloqueo neuromuscular en SIRA, que dijo mi mamá que siempre no :( https://t.co/RhbamyQlXr